Lysophosphatidylcholine induces the production of IL-1β by human monocytes

Atherosclerosis

Volumn 137, Issue 2, 1998, Pages 351-357

  Liu Wu, Yani ^a   Hurt Camejo, Eva ^a   Wiklund, Olov ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Atherosclerosis; Cytokines; Inflammation; Lysophosphatidylcholine; Monocyte

Indexed keywords

INTERLEUKIN 1BETA; LYSOPHOSPHATIDYLCHOLINE;

ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; HUMAN; HUMAN CELL; INFLAMMATION; MONOCYTE; PRIORITY JOURNAL;

ARTERIOSCLEROSIS; CELLS, CULTURED; DNA PRIMERS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERLEUKIN-1; LYSOPHOSPHATIDYLCHOLINES; MONOCYTES; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS;

EID: 0032055384     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00295-5     Document Type: Article

References (42)

1. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol, modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 320:1989;915-924.
2. Steinbrecher U.P., Parthasarathy S., Leake D.S., Witztum J.L., Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA. 81:1984;3883-3887.
3. Portman O.W., Alexander M. Lysophosphatidylcholine concentrations and metabolism in aortic intima plus inner media: effect of nutritionally induced atherosclerosis. J Lipid Res. 10:1969;158-165.
4. Böttcher C., Van Gent C. Changes in the composition of phospholipids and of phospholipid fatty acids associated with atherosclerosis and the human aortic wall. J Atheroscler Res. 1:1961;36-46.
5. Keaney J.F. Jr., Xu A., Cunningham D., Jackson T., Frei B., Vita J.A. Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation. J Clin Invest. 95:1995;2520-2529.
6. 2 in normal and atherosclerotic arteries. Activity of the isolated enzyme on the low-density lipoproteins. Arterioscler Thromb Vasc Biol. 17:1997;300-309.
7. Kume N., Cybulsky M.I., Gimbrone J.M.A. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest. 90:1992;1138-1144.
8. Kume N., Gimbrone J.M.A. Lysophospatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J Clin Invest. 93:1994;907-911.
9. Yokoyama M., Hirata K.-I., Miyake R., Akita H., Ishikawa Y., Fukuzaki H. Lysophosphatidylcholine: essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein. Biochem Biophys Res Commun. 168:1990;301-308.
10. Murohara T., Kugiyama K., Ohgushi M., Sugiyama S., Ohta Y., Yasue H. LPC in oxidized LDL elicits vasocontraction and inhibits endothelium-dependent relaxation. Am J Physiol. 267:1994;H2441-H2449.
11. Sakai M., Miyazaki A., Hakamata H., Sasaki T., Yui S., Yamazaki M., Shichiri M., Horiuchi S. Lysophatidylcholine plays an essential role in the mitogenic effect of oxidized low density lipoprotein on murine macrophages. J Biol Chem. 269:1994;31430-31435.
12. Chai Y.-C., Howe P.H., DiCorleto P.E., Chisolm G.M. Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cells. J Biol Chem. 271:1996;17791-17797.
13. 2 in signal transduction through protein kinase C. Proc Natl Acad Sci USA. 89:1992;6447-6451.
14. Murugesan G., Fox P.L. Role of lysophosphatidylcholine in the inhibition of endothelial cell motility by oxidized low density lipoprotein. J Clin Invest. 97:1996;2736-2744.
15. Gown A.M., Tsukada T., Ross R. Human atherosclerosis II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol. 125:1986;191-207.
16. Liu Y., Mattsson-Hultén L., Wiklund O. Macrophages isolated from human atherosclerotic plaques produce IL-8, and oxysterols may have a regulatory function for IL-8 production. Arterioscler Thromb Vasc Biol. 17:1997;317-323.
17. The committee on enzymes of the Scandinavian Society for clinical chemistry and clinical physiology Recommended methods for the determination of four enzymes in blood. Scand J Clin Lab Invest. 33:1974;291-306.
18. Bradford M.A. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1976;248-254.
19. Mattsson-Hultén L., Johansson H., Diczfalusy U., Björkhem I., Ottosson M., Liu Y., Bondjers G., Wiklund O. Oxysterols present in atherosclerotic tissue decrease the expression of lipoprotein lipase messenger RNA in human monocyte-derived macrophages. J Clin Invest. 97:1996;461-468.
20. Wang A.M., Doyle M.V., Mark D.F. Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci USA. 86:1989;9717-9721.
21. Thumser A.E.A., Voysey J.E., Wilton D.C. The binding of lysophospholipids to rat liver fatty acid-binding protein and albumin. Biochem J. 301:1994;801-806.
22. Quinn M.T., Kondratenko N., Parthasarathy S. Analysis of the monocyte chemotactic response to lysophosphatidylcholine: role of lysophospholipase C. Biochim Biophys Acta. 1082:1991;293-302.
23. Yuan Y., Schoenwaelder S.M., Salem H.H., Jackson S.P. The bioactive phospholipid, lysophosphatidylcholine, induces cellular effects via G-protein-dependent activation of adenylyl cyclase. J Biol Chem. 271:1996;27090-27098.
24. Ohara Y., Peterson T.E., Zheng B., Kuo J.F., Harrison D.G. Lysophosphatidylcholine increases vascular superoxide anion production via protein kinase C activation. Arterioscler Thromb. 14:1994;1007-1013.
25. Sugiyama S., Kugiyama K., Ohgushi M., Fujimoto K., Yasue H. Lysophosphatidylcholine in oxidized low-density lipoprotein increases endothelial susceptibility to polymorphonuclear leukocyte-induced endothelial dysfunction in porcine coronary arteries: Role of protein kinase C. Circ Res. 74:1994;565-575.
26. Murohara T., Scalia R., Lefer A.M. Lysophsphatidylcholine promotes P-selectin expression in platelets and endothelial cells Possible involvement of protein kinase C activation and its inhibition by nitric oxide donors. Circ Res. 78:1996;780-789.
27. Liu S.-Y., Lu X., Choy S., Dembinski T.C., Hatch G.M., Mymin D., Shen S., Angel A., Choy P.C., Man R.Y.K. Alteration of lysophosphatidylcholine content in low density lipoprotein after oxidative modification: relationship to endothelium dependent relaxation. Cardiovasc Res. 28:1994;1476-1481.
28. Itabe H., Takeshima E., Iwasaki H., Kimura J., Yoshida Y., Imanaka T., Takano T. A monoclonal antibody against oxidized liprotein recognizes foam cells in atherosclerotic lesions. J Biol Chem. 269:1994;15274-15279.
29. 2 in rheumatoid synovial fluid. Life Sci. 36:1985;579-587.
30. Mattsson L., Johansson H., Ottosson M., Bondjers G., Wiklund O. Expression of lipoprotein lipase mRNA and secretion in macrophages isolated from human atherosclerotic aorta. J Clin Invest. 92:1993;1759-1765.
31. O'Brien K.D., Gordon D., Deeb S., Ferguson M., Chait A. Lipoprotein lipase is synthesízed by macrophage-derived foam cells in human coronary atherosclerotic plaques. J Clin Invest. 89:1992;1544-1550.
32. Ylä-Hertuala S., Lipton B.A., Rosenfield M.E., Goldberg I.J., Steinberg D., Witztum J.L. Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA. 88:1991;10143-10147.
33. Moyer C.F., Sajuthi D., Tulli H., Williams J.K. Synthesis of IL-1 alpha and IL-1 beta by arterial cells in atherosclerosis. Am J Pathol. 138:1991;951-960.
34. Tipping P.G., Hancock W.W. Production of tumor necrosis factor and interleukin-1 by macrophages from human atheromatous plaques. Am J Pathol. 142:1993;1721-1728.
35. Bevilacqua M.P., Pober J.S., Majeau G.R., Fiess W., Cotran R.S., Gimbrone M.A.J. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: Characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci USA. 83:1986;4537-4542.
36. Martin S., Murata K., Burkart V., Gillis S., Kolb H. Interleukin 1 and IFN-gamma increase vascular permeability. Immunology. 64:1988;301-305.
37. Libby P., Wyler D.J., Janicka M.W., Dinarello C.A. Differential effects of human interleukin-1 on growth of fibroblasts and vascular smooth muscle cells. Arteriosclerosis. 5:1985;186-191.
38. Bonin P.D., Fici G.J., Singh J.P. Interleukin-1 promotes proliferation of vascular smooth muscle cells in coordination with PDGF or a monocyte-derived factor. Exp Cell Res. 181:1989;475-484.
39. Bevilacqua M.P., Pober J.S., Wheeler M.E., Cotran R.S., Gimbrone J.M.A. Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. J Clin Invest. 76:1985;2003-2011.
40. Cavender D.E., Haskard D.O., Joseph B., Ziff M. Interleukin 1 increases the binding of human B and T lymphocytes to endothelial cell monolayers. J Immunol. 136:1986;203-207.
41. 2 in human synovial cells. Arthritis Rheum. 31:1988;126-130.
42. 2-activating protein, and release of linoleic acid from the murine T helper cell line EL-4. J Immunol. 148(1):1992;155-160.